Form4insider filings, from the source

SEC Form 4 · accession 0001144204-19-012635

Cytosorbents Corp · CTSO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Kathleen P. Bloch
Officer — Chief Financial Officer
Period of report
Mar 4, 2019
Accepted (ET)
Mar 6, 2019 · 9:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175151

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Mar 4, 2019A4,070$0.00A242,725D
Common StockF3holding———9,000ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses